Co-Diagnostics, Inc. (MUN:C97)
0.3320
0.00 (0.00%)
At close: Nov 26, 2025
Co-Diagnostics Revenue
Co-Diagnostics had revenue of $145.38K USD in the quarter ending September 30, 2025, a decrease of -77.32%. This brings the company's revenue in the last twelve months to $507.89K, down -93.06% year-over-year. In the year 2024, Co-Diagnostics had annual revenue of $3.92M, down -42.53%.
Revenue (ttm)
$507.89K
Revenue Growth
-93.06%
P/S Ratio
45.28
Revenue / Employee
$3.85K
Employees
132
Market Cap
19.60M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.92M | -2.90M | -42.53% |
| Dec 31, 2023 | 6.81M | -27.41M | -80.09% |
| Dec 31, 2022 | 34.22M | -63.67M | -65.04% |
| Dec 31, 2021 | 97.89M | 23.33M | 31.30% |
| Dec 31, 2020 | 74.55M | 74.34M | 34,579.90% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |
Co-Diagnostics News
- 3 days ago - CoDiagnostics (CODX) Upgraded to Buy: Here's What You Should Know - Nasdaq
- 9 days ago - Co-Diagnostics (CODX) Initiated with 'Buy' Rating by Maxim Group | CODX Stock News - GuruFocus
- 11 days ago - HC Wainwright Reiterates Neutral Rating for Co-Diagnostics (CODX) | CODX Stock News - GuruFocus
- 15 days ago - Co-Diagnostics Delivers Address about Tuberculosis Test Adoption and Implementation at The Union World Conference on Lung Health - PRNewsWire
- 17 days ago - Co-Diagnostics Initiates Clinical Evaluations for Upper Respiratory Multiplex Point-of-Care Test on Co-Dx™ PCR Platform to Support Submission to the U.S. FDA - PRNewsWire
- 22 days ago - Co-Diagnostics Inc (CODX) Q3 2025 Earnings Call Highlights: Strategic Ventures and Financial ... - GuruFocus
- 22 days ago - Q3 2025 Co-Diagnostics Inc Earnings Call Transcript - GuruFocus
- 22 days ago - Co-Diagnostics, Inc. (CODX) Q3 2025 Earnings Call Transcript - Seeking Alpha